All News

The annual gathering drew leaders from across the industry, including pioneering consultants Specialdocs and 10 of its affiliated physicians.

With denials cutting deeper into practice revenue, physicians are turning to AI-driven tools to catch errors before submission, automate appeals and reduce administrative burnout.

Sara Gerke outlines two possible futures for AI in medicine — one that prevents malpractice claims, and one that multiplies them.

Jupiter Endovascular's innovative TFX technology shows promise in improving outcomes for pulmonary embolism patients, enhancing safety and procedural efficiency.

David Ford, CEO of CMA Physician Services, joins the show to explain how Medway helps independent physicians offload administrative burdens so they can focus on patient care.

Analyst Trilliant Health argues the case for major changes from inside — or new regulations from outside.

Sara Gerke says professional guidance, clear labeling and education will be critical to protect physicians from new AI-related liability risks.

The top news stories in medicine today.

With denials cutting deeper into practice revenue, physicians are turning to AI-driven tools to catch errors before submission, automate appeals and reduce administrative burnout.

With denials cutting deeper into practice revenue, physicians are turning to AI-driven tools to catch errors before submission, automate appeals and reduce administrative burnout.

With denials cutting deeper into practice revenue, physicians are turning to AI-driven tools to catch errors before submission, automate appeals and reduce administrative burnout.

A new survey from Smarter Technologies and MedCity News shows hospitals and practices waiting months for payment, battling costly billing software and turning to AI for relief.

A new study suggests pharmacy technicians can ease physicians’ administrative load and improve patient access. Can practices afford not to hire them?

Sara Gerke explores the legal and ethical gray areas of disclosing AI use in patient care — and why “proportionate transparency” may be the fairest path forward.

To sustain Medicare Advantage, payers and providers must rebuild collaboration through transparency and standardization.

With denials cutting deeper into practice revenue, physicians are turning to AI-driven tools to catch errors before submission, automate appeals and reduce administrative burnout.

Analyst Trilliant Health argues the case for major changes from inside — or new regulations from outside.

Aerin Medical device uses temperature- and impedance-controlled radiofrequency to treat multiple anatomical drivers of chronic rhinitis

How will artificial intelligence reshape the rules of medical malpractice? Northeastern University’s David Simon unpacks the legal, ethical and practical dilemmas now confronting physicians, hospitals and AI developers.

The top news stories in medicine today.

David Simon, J.D., LL.M., Ph.D., looks ahead at how widespread AI adoption may de-skill physicians, trigger early waves of litigation and push courts to create new legal norms for medical technology.

A new educational effort from Ipsen spotlights one of medicine’s most overlooked weak points: the transition from pediatric to adult care.

Sara Gerke discusses her proposal for AI “facts labels,” arguing that transparency in device labeling could help physicians, health systems and regulators share accountability.

David Simon, J.D., LL.M., Ph.D., says AI could cut malpractice claims if it becomes part of the accepted standard of care — but shift liability toward manufacturers in product defect cases.

Bain & Company finds hospitals accelerating investment in primary care and value-based care, even as labor shortages and patient skepticism over AI threaten progress.

Sara Gerke shares new findings from the CLASSICA project, revealing how surgeons view AI liability — and why shared accountability may be the future of malpractice law.

State-level scrutiny of private equity in health care intensifies as new laws emerge, shifting focus from federal antitrust enforcement.

David Simon, J.D., LL.M., Ph.D., contrasts the European Union’s proactive approach to AI oversight with the U.S. system’s reliance on courts and the FDA — and argues for a middle path balancing innovation and accountability.